癌症忠诚度卡研究(CLOCS)中季节性购买抗组胺药与卵巢癌症风险:观察性病例对照研究结果

IF 1.6 Q3 HEALTH CARE SCIENCES & SERVICES
H. Brewer, Q. Jiang, S. Sundar, Y. Hirst, J. Flanagan
{"title":"癌症忠诚度卡研究(CLOCS)中季节性购买抗组胺药与卵巢癌症风险:观察性病例对照研究结果","authors":"H. Brewer, Q. Jiang, S. Sundar, Y. Hirst, J. Flanagan","doi":"10.1101/2023.05.30.23290729","DOIUrl":null,"url":null,"abstract":"Objective: Antihistamine use has previously been associated with a reduction in incidence of ovarian cancer, particularly in premenopausal women. Herein, we investigate antihistamine exposure in relation to ovarian cancer risk using a novel data resource by examining purchase histories from retailer loyalty card data. Study Design: A subset of participants from the Cancer Loyalty Card Study (CLOCS) for which purchase histories were available were analysed in this study. Cases (n=153) were women in the UK with a first diagnosis of ovarian cancer between Jan 2018 to Jan 2022. Controls (n=120) were women in the UK without a diagnosis of ovarian cancer. Up to 6 years of purchase history was retrieved from two participating high street retailers from 2014 to 2022. Main outcome measures: Logistic regression was used to estimate the odds ratio (OR) and 95% confidence intervals (CIs) for ovarian cancer associated with antihistamine purchases, ever versus never, adjusting for age and oral contraceptive use. The association was stratified by season of purchase, age over and under 50 years, ovarian cancer histology, and family history. Results: Ever purchasing antihistamines was not significantly associated with ovarian cancer overall in this small study (OR:0.68, 95% CI: 0.39,1.19). However, antihistamine purchases were significantly associated with reduced ovarian cancer risk when purchased only in spring and/or summer (OR: 0.37, 95% CI: 0.17,0.82) compared with purchasing all year (OR: 0.99, 95% CI: 0.51,1.92). In the stratified analysis, the association was strongest in non-serous ovarian cancer (OR: 0.41, 95% CI:0.18,0.93). Conclusions: Antihistamine purchase is associated with reduced ovarian cancer risk when purchased seasonally in spring and summer. However, larger studies and more research is required to understand the mechanisms of reduced ovarian cancer risk related to seasonal purchases of antihistamines and allergies.","PeriodicalId":36483,"journal":{"name":"International Journal of Population Data Science","volume":"1 1","pages":""},"PeriodicalIF":1.6000,"publicationDate":"2023-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Seasonal purchase of antihistamines and ovarian cancer risk in the Cancer Loyalty Card Study (CLOCS): results from an observational case-control study\",\"authors\":\"H. Brewer, Q. Jiang, S. Sundar, Y. Hirst, J. Flanagan\",\"doi\":\"10.1101/2023.05.30.23290729\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Objective: Antihistamine use has previously been associated with a reduction in incidence of ovarian cancer, particularly in premenopausal women. Herein, we investigate antihistamine exposure in relation to ovarian cancer risk using a novel data resource by examining purchase histories from retailer loyalty card data. Study Design: A subset of participants from the Cancer Loyalty Card Study (CLOCS) for which purchase histories were available were analysed in this study. Cases (n=153) were women in the UK with a first diagnosis of ovarian cancer between Jan 2018 to Jan 2022. Controls (n=120) were women in the UK without a diagnosis of ovarian cancer. Up to 6 years of purchase history was retrieved from two participating high street retailers from 2014 to 2022. Main outcome measures: Logistic regression was used to estimate the odds ratio (OR) and 95% confidence intervals (CIs) for ovarian cancer associated with antihistamine purchases, ever versus never, adjusting for age and oral contraceptive use. The association was stratified by season of purchase, age over and under 50 years, ovarian cancer histology, and family history. Results: Ever purchasing antihistamines was not significantly associated with ovarian cancer overall in this small study (OR:0.68, 95% CI: 0.39,1.19). However, antihistamine purchases were significantly associated with reduced ovarian cancer risk when purchased only in spring and/or summer (OR: 0.37, 95% CI: 0.17,0.82) compared with purchasing all year (OR: 0.99, 95% CI: 0.51,1.92). In the stratified analysis, the association was strongest in non-serous ovarian cancer (OR: 0.41, 95% CI:0.18,0.93). Conclusions: Antihistamine purchase is associated with reduced ovarian cancer risk when purchased seasonally in spring and summer. However, larger studies and more research is required to understand the mechanisms of reduced ovarian cancer risk related to seasonal purchases of antihistamines and allergies.\",\"PeriodicalId\":36483,\"journal\":{\"name\":\"International Journal of Population Data Science\",\"volume\":\"1 1\",\"pages\":\"\"},\"PeriodicalIF\":1.6000,\"publicationDate\":\"2023-06-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Population Data Science\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1101/2023.05.30.23290729\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"HEALTH CARE SCIENCES & SERVICES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Population Data Science","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1101/2023.05.30.23290729","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

摘要

目的:抗组胺药物的使用与卵巢癌症发病率的降低有关,尤其是在绝经前妇女中。在此,我们通过检查零售商忠诚度卡数据中的购买历史,使用一种新的数据资源,研究抗组胺药物暴露与卵巢癌症风险的关系。研究设计:本研究分析了癌症忠诚度卡研究(CLOCS)的一部分参与者,他们有购买历史。病例(n=153)为2018年1月至2022年1月期间首次诊断为卵巢癌症的英国女性。对照组(n=120)为英国未被诊断为卵巢癌症的女性。2014年至2022年,从两家参与的商业街零售商那里检索到了长达6年的购买历史。主要结果指标:使用Logistic回归来估计卵巢癌症与抗组胺药购买相关的比值比(OR)和95%置信区间(CI),无论是否购买,均根据年龄和口服避孕药使用进行调整。根据购买季节、50岁以上和50岁以下年龄、卵巢癌症组织学和家族史对这种关联进行分层。结果:在这项小型研究中,购买抗组胺药与卵巢癌症总体无显著相关性(OR:0.68,95%CI:0.39,1.19),与全年购买(or:0.99,95%CI:0.51,1.92)相比,仅在春季和/或夏季购买抗组胺药与降低卵巢癌症风险显著相关(or:0.37,95%CI:0.17,0.82)。在分层分析中,结论:春季和夏季季节性购买抗组胺药物可降低卵巢癌症风险。然而,需要更大规模的研究和更多的研究来了解与季节性购买抗组胺药和过敏相关的卵巢癌症风险降低的机制。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Seasonal purchase of antihistamines and ovarian cancer risk in the Cancer Loyalty Card Study (CLOCS): results from an observational case-control study
Objective: Antihistamine use has previously been associated with a reduction in incidence of ovarian cancer, particularly in premenopausal women. Herein, we investigate antihistamine exposure in relation to ovarian cancer risk using a novel data resource by examining purchase histories from retailer loyalty card data. Study Design: A subset of participants from the Cancer Loyalty Card Study (CLOCS) for which purchase histories were available were analysed in this study. Cases (n=153) were women in the UK with a first diagnosis of ovarian cancer between Jan 2018 to Jan 2022. Controls (n=120) were women in the UK without a diagnosis of ovarian cancer. Up to 6 years of purchase history was retrieved from two participating high street retailers from 2014 to 2022. Main outcome measures: Logistic regression was used to estimate the odds ratio (OR) and 95% confidence intervals (CIs) for ovarian cancer associated with antihistamine purchases, ever versus never, adjusting for age and oral contraceptive use. The association was stratified by season of purchase, age over and under 50 years, ovarian cancer histology, and family history. Results: Ever purchasing antihistamines was not significantly associated with ovarian cancer overall in this small study (OR:0.68, 95% CI: 0.39,1.19). However, antihistamine purchases were significantly associated with reduced ovarian cancer risk when purchased only in spring and/or summer (OR: 0.37, 95% CI: 0.17,0.82) compared with purchasing all year (OR: 0.99, 95% CI: 0.51,1.92). In the stratified analysis, the association was strongest in non-serous ovarian cancer (OR: 0.41, 95% CI:0.18,0.93). Conclusions: Antihistamine purchase is associated with reduced ovarian cancer risk when purchased seasonally in spring and summer. However, larger studies and more research is required to understand the mechanisms of reduced ovarian cancer risk related to seasonal purchases of antihistamines and allergies.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
2.50
自引率
0.00%
发文量
386
审稿时长
20 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信